Magnesium SO4 is one of 104 small molecule programs targeting Cesarean Section. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
137 competitors in Atrial Fibrillation
Magnesium SO4
Calquence
Rituxan
Coumadin
Brukinsa
Imbruvica
Versed
Ondexxya
Romazicon
Statin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details